Where borders meet: Psoriasic arthritis and the cardiovascular risk (original) (raw)

Cardiovascular risk in psoriatic arthritis - a cross-sectional study

Violeta Claudia Bojinca

Maedica, 2014

View PDFchevron_right

Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study

Christie Bartels

Arthritis care & research, 2017

View PDFchevron_right

The Number of Traditional Cardiovascular Risk Factors Is Independently Correlated with Disease Activity in Patients with Psoriatic Arthritis

Ricardo Blanco

Medicina

View PDFchevron_right

Higher Risk of Future Cardiovascular Events Among Patients with Psoriatic Arthritis Compared to Psoriatic Patients Between the Ages of 30-50

Agnieszka Owczarczyk-Saczonek

The Open Dermatology Journal

View PDFchevron_right

Cardiovascular Risk in Patients with Psoriatic Arthritis

Edmund Li

International Journal of Rheumatology, 2012

View PDFchevron_right

Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis

Lihi Eder

Arthritis Care & Research, 2011

View PDFchevron_right

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients

Raffaele Scarpa

Reviews on recent clinical trials, 2018

View PDFchevron_right

Psoriatic arthritis and risk of overt cardiovascular disease: review of the evidence

Janice Husted

International Journal of Clinical Rheumatology, 2012

View PDFchevron_right

Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation

Brian Tomlinson, Ying Ying Leung

Rheumatology (Oxford, England), 2008

View PDFchevron_right

Cardiovascular comorbidities in psoriatic arthritis - study of patients from the Republic of Moldova

Lucia Dutca

Moldovan Journal of Health Sciences

View PDFchevron_right

Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis

Edmund Li

The Journal of rheumatology, 2017

View PDFchevron_right

Cardiovascular Risk in Psoriatic Arthritis: Search for New Biological Markers

Shandor Erdes

Psoriasis Forum, 2010

View PDFchevron_right

Prevalence and Risk Factors of Atherosclerosis in Patients with Psoriatic Arthritis

Nitsan Maharshak

Seminars in Arthritis and Rheumatism, 2007

View PDFchevron_right

Prevention and risk assessment of cardiovascular events in a population of patients with psoriasis and psoriatic arthritis

Brygida Kwiatkowska

Rheumatology

View PDFchevron_right

Modifications of Cardiovascular Risk Scores, But Not Standard Risk Scores, Improve Identification of Asymptomatic Coronary Artery Disease in Psoriatic Arthritis

Oliver Fitzgerald

The Journal of rheumatology, 2018

View PDFchevron_right

Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis

Roxanne Cooksey

Seminars in arthritis and rheumatism, 2018

View PDFchevron_right

A comparison of disease impact according to the cardiometabolic risk profile in psoriatic arthritis

Rubén Queiro

Archives of Medical Science : AMS, 2021

View PDFchevron_right

Impact of cardiovascular risk factors on the achievement of therapeutic goals in psoriatic arthritis: is there any association?

juan canete

Clinical rheumatology, 2018

View PDFchevron_right

High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

Carlos Gonzalez-juanatey

Arthritis & Rheumatism, 2007

View PDFchevron_right

Subclinical atherosclerosis in psoriatic arthritis: a case-control study

Doron Rimar

The Journal of rheumatology, 2008

View PDFchevron_right

Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors

Rodolfo Kolliker Frers

Frontiers in immunology, 2018

View PDFchevron_right

Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis

Amit Kumer Dey

The Journal of Rheumatology, 2019

View PDFchevron_right

Higher Coronary Plaque Burden in Psoriatic Arthritis is Independent of Metabolic Syndrome and Associated with Underlying Disease Severity

Oliver Fitzgerald

Arthritis & rheumatology (Hoboken, N.J.), 2017

View PDFchevron_right

Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis

Lihi Eder

Annals of the rheumatic diseases, 2014

View PDFchevron_right

Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease

Edmund Li

Annals of the rheumatic diseases, 2017

View PDFchevron_right

The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone

Lihi Eder

Annals of the Rheumatic Diseases, 2013

View PDFchevron_right

The Framingham Risk Score underestimates the extent of subclinical atherosclerosis in patients with psoriatic disease

Lihi Eder

Annals of the Rheumatic Diseases, 2013

View PDFchevron_right

A hospital based study to assess the prevalence of cardiovascular risk factors among patients of chronic plaque psoriasis

Naina Dogra

International Journal of Research in Medical Sciences, 2016

View PDFchevron_right

Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Arthritis

Susana Armesto

The Journal of Rheumatology, 2019

View PDFchevron_right

Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated

Lianne Pouw

RMD Open, 2023

View PDFchevron_right

Psoriasis and cardiovascular risk: Immune-mediated crosstalk between metabolic, vascular and autoimmune inflammation

José Milei

IJC Metabolic & Endocrine, 2015

View PDFchevron_right

Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study

O. Ahlehoff

Journal of Internal Medicine, 2010

View PDFchevron_right